Eikonoklastes Therapeutics Company

Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.


Investors

Last Funding Type: Seed
Funding Status: Seed
Headquarters: Cincinnati, Ohio, United States
Founded Date: 2019-01-01
Last Funding Date: 2020-03-04
Total Funding: $2 800 000
Estimated Revenue: $1M to $10M
Industry: Longevity